BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Circassia Finally Throws In The Towel On Allergy Program After Trial Failures

  April 18, 2017

   · 

  6 min read
• Pharm Country

  Interpace Diagnostics Announces Coverage Of ThyraMIR With UnitedHealthcare

  April 18, 2017

   · 

  6 min read
• Enzyvant Sciences Receives FDA Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Investigational Therapy RVT-802

  April 18, 2017

   · 

  4 min read
• Business

  Lombard Medical CEO Steps Down, Effective Immediately

  April 18, 2017

   · 

  1 min read
• ASLAN To Present At The 2017 Taiwan Drug Development & Medical Device Symposium

  April 18, 2017

   · 

  2 min read
• Business

  Avadel Pharma To Report First Quarter 2017 Results

  April 18, 2017

   · 

  3 min read
• Genetown

  Agios Announces Proposed Offering Of Common Stock

  April 18, 2017

   · 

  4 min read
• BioBlast Pharma Announces Plans In Response To Nasdaq Notifications Regarding Stockholders’ Equity And Minimum Bid Requirements

  April 18, 2017

   · 

  3 min read
• Spirax Sarco To Speak At The Food Automation And Manufacturing Conference 2017

  April 18, 2017

   · 

  2 min read
• Drug Development

  Protalix Announces New Preclinical Results Demonstrating A Positive Effect Of Pegunigalsidase Alfa (PRX-102) On Small-Fiber Neuropathy In Fabry Disease Models Compared To Commercially Available Enzyme Replacement Therapies

  April 18, 2017

   · 

  5 min read